Journals / TSK Koruyucu Hekimlik Bülteni / 2011 / Cilt: 10 - Sayı: 3

Hantavirus infections and prevention of hantaviruses

Hantavirüs enfeksiyonları ve önlenmesi

Pages
373–378
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this manuscript hantavirus infections, hantavirus types, epidemiology, ways of transmission, risk groups and prevention methods were reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hantavirus infections are in the notifiable disease list under the viral hemorrhagic disease group.Climate change and its effect on the rodent population could make hantavirus infections a public health threat.
📊
Key Findings & Data:Hantavirus infections are in the notifiable disease list under the viral hemorrhagic disease group.Climate change and its effect on the rodent population could make hantavirus infections a public health threat.
💡
Conclusion & Impact:In this manuscript hantavirus infections, hantavirus types, epidemiology, ways of transmission, risk groups and prevention methods were reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hantavirus infections are in the notifiable disease list under the viral hemorrhagic disease group.Climate change and its effect on the rodent population could make hantavirus infections a public health threat. In this manuscript hantavirus infections, hantavirus types, epidemiology, ways of transmission, risk groups and prevention methods were reviewed.

Özet

Hantavirus enfeksiyonları viral kanamalı ateşli hastalıklar başlığı altında bildirimi zorunlu hastalıklardandır. İklim değişikliklerinin kemirgen populasyonuna yansıması ile önemli bir halk sağlığı tehdidi oluşturabilmektedir. Bu yazıda hantavirus enfeksiyonları, hantavirus tipleri,dünyada ve ülkemizde hanta virus epidemiyolojisi, bulaş yolu ve risk grupları, klinik bulgular, tanı yöntemleri ve serolojik testler, sağaltım ve önlemeye yönelik çalışmalar konusundaki bilgilere yer verilmiştir

🔖

Cite This Article

ALTUN, D. U., ÖKTEM, İ. M. A., ÜNAL, B. (2011). Hantavirus infections and prevention of hantaviruses. TSK Koruyucu Hekimlik Bülteni, Cilt: 10 - Sayı: 3, 373–378. https://ajindex.com/articles/129752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. 1Oktem MA. Hantavirus ve Kene ile Bulaşan Ensefalit Virusu Enfeksiyonları. ANKEM Derg 2009; 23(Ek 2): 245-248. 2 Vapalahti O, Mustonen J, Lundkvist A, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis. 2003; 3(10): 653-661. 3 Heyman P, Vaheri A, Lundkvist A, Avsic-Zupanc T. Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther. 2009; 7(2): 205-217. 4 Lee HW, Lee PW. Korean Hemorrhagic fever. I. Demonstration of causative antigen and antibodies. Korean Journal of Interneal Medicine. 1976; 19: 371-383. 5 Lee HW, Lee PW, Lohnson KM. Isolation of the etiologic agent of the Korean Hemorrhagic fever. J Infect Dis. 1978; 137: 298-308. 6 Chandy S, Abraham P, Sridharan G. Hantaviruses: an emerging public health threat in India? A review. J Biosci. 2008; 33(4): 495-504. 7 Muranyi W, Bahr U, Zeier M, van der Woude FJ. Hantavirus infection. J Am Soc Nephrol. 2005; 16(12): 3669-3679. 8 Klempa B. Hantaviruses and climate change. Clin Microbiol Infect. 2009; 15(6): 518-523. 9 Bi Z, Formenty PB, Roth CE. Hantavirus Infection: a review and global update. J Infect Dev Ctries. 2008; 2(1): 3-23. 10 Öktem MA, Hantavirus Sempozyumu. Ankara. 2010, s. 33-36. 11 Ahlm C, Linderholm M, Juto P, Stegmayr B, Settergren B. Prevalence of serum IgG antibodies to Puumala virus (haemorrhagic fever with renal syndrome) in northern Sweden. Epidemiol Infect. 1994; 113(1): 129-136. 12 Pejcoch M, Kriz B. Prevalence of antibodies against hantaviruses among the adult population of the Czech Republic. Cent Eur J Public Health. 2003; 11(3): 169-172. 13 Golovljova I, Sjölander KB, Lindegren G, et al. Hantaviruses in Estonia. J Med Virol. 2002; 68(4): 589-598. 14 Sibold C, Meisel H, Lundkvist A, et al. Short report: simultaneous occurrence of Dobrava, Puumala, and Tula Hantaviruses in Slovakia. Am J Trop Med Hyg. 1999; 61(3): 409-411. 15 Alexeyev OA, Elgh F, Zhestkov AV, Wadell G, Juto P. Hantaan and Puumala virus antibodies in blood donors in Samara, an HFRS-endemic region in European Russia. Lancet. 1996; 347(9013): 1483. 16 Zöller L, Faulde M, Meisel H, et al. Seroprevalence of hantavirus antibodies in Germany as determined by a new recombinant enzyme immunoassay. Eur J Clin Microbiol Infect Dis. 1995; 14(4): 305-313. 17 Brummer-Korvenkontio M, Vapalahti O, Henttonen H, Koskela P, Kuusisto P, Vaheri A. Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis. 1999; 31(5): 4